• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:宋振民,蒋陆霞,马艳红,陈菲,张宏伟.肺痿合剂对肺癌脑转移化疗患者唾液酸水平的影响研究[J].药学研究,2016,35(5):300-302[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3816次   下载 2820次 本文二维码信息
码上扫一扫!
肺痿合剂对肺癌脑转移化疗患者唾液酸水平的影响研究
宋振民,蒋陆霞,马艳红,陈菲,张宏伟
字体:加大+|默认|缩小-
(聊城市人民医院,山东 聊城 252000)
摘要:
目的 探讨肺痿合剂对肺癌脑转移患者唾液酸水平及治疗效果的影响。方法 选取在2013年1月~2015年12月期间收治的肺癌脑转移患者共87例,其中采用肺痿合剂治疗的患者41例作为观察组,未采用肺痿合剂治疗的患者46例作为对照组,观察两组患者的临床治疗效果及唾液酸水平的变化。结果 在化疗前,两组患者的唾液酸水平无显著差异(P>0.05);两组患者治疗后与治疗前组内比较,均显著下降,有统计学差异(P<0.05);化疗2个周期后,组间比较,观察组唾液酸显著低于对照组患者,有统计学差异(P<0.05)。化疗2个周期后,根据WHO评价标准对两组患者治疗效果进行评定,观察组患者临床缓解率显著高于对照组患者,有统计学差异(χ2=4.370,P<0.05)。结论 肺痿合剂能够显著提高肺癌脑转移患者的治疗效果,降低唾液酸水平,临床效果满意。
关键词:  肺痿合剂  肺癌  脑转移  唾液酸
DOI:10.13506/j.cnki.jpr.2016.05.014
基金项目:
Influence of Feiwei Mixture in chemotherapy patients with brain metastasis of lung cancer about sialic acid levels
SONG Zhenmin,JIANG Luxia,MA Yanhong,CHEN Fei,ZAHNG Hongwei
(Liaocheng People’s Hospital,Liaocheng 252000,China)
Abstract:
Objective To investigate the effect of Feiwei Mixture in chemotherapy patients with brain metastasis of lung cancer about sialic acid levels.Methods A total of 87 patients were selected from the hospital from January 2013 to December 2015 with lung cancer brain metastasis, Feiwei Mixture treated patients 41 cases as the observation group, other 46 patients as control group, the changes of two groups of patients with clinical curative effect and sialic acid level were observed. Results There was no significant difference in pre-chemotherapy, sialic acid levels in the two groups of patients (P>0.05); The two groups of patients after treatment compared with before treatment group, were significantly decreased,there was significant difference (P<0.05);After 2 cycles of chemotherapy, comparison between groups were made,the observation group was significantly lower than that of sialic acid in control group,there was significant difference (P<0.05). After 2 cycles of chemotherapy, the efficacy of two groups of patients were assessed by WHO criteria, the clinical remission rate of patients in the observation group was significantly higher than that of the patients in the control group, there was statistically significant difference (χ2=4.370, P<0.05). Conclusion Feiwei Mixture can significantly improve the effect of the treatment of patients with brain metastases from lung cancer,reduce the sialic acid level, satisfactory clinical effect.
Key words:  Feiwei Mixture  Lung cancer  Brain metastasis  Sialic acid
今日访问量:2643    总访问量:55339157
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司